Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Before taking Paxlovid, consider these drug interactions

Param Patel, PharmD
Meds
April 7, 2022
39 Shares
Share
Tweet
Share

FDA and Health Canada recently approved Paxlovid as an oral treatment option for mild-to-moderate COVID-19 who are at high risk of progression to severe COVID-19. It is a combination drug containing nirmatrelvir/ritonavir. Nirmatrelvir works by binding to SARS-CoV-2 3CL protease to ultimately stop viral replication. Ritonavir does not have any antiviral activity against COVID-19 but increases concentrations of nirmatrelvir by decreasing its metabolism by CYP3A4 enzyme. Ritonavir is a potent inhibitor of CYP3A4 and various drug transporters such as P-glycoprotein. CYP3A4 and P-glycoprotein are involved in the metabolism and elimination of many commonly prescribed drugs. Thus it is very important to review a patient’s current medication regimen to check for clinically significant interactions.

Potential medication interaction management options may include depending on the medication:

  • Holding the interacting medication and resuming two days after completing the Paxlovid course
  • Using an alternative medication that does not interact or adjusting the dose of the interacting medication while on Paxlovid
  • Use an alternative COVID-19 agent.

I will discuss Paxlovid interactions with some commonly prescribed medications and potential management options. It is not an exhaustive list, and a pharmacist consultation with the patient may be helpful before prescribing Paxlovid for a comprehensive review of interactions.

CYP3A-4 inducing medications 

Paxlovid is contraindicated in patients taking any CYP3A4 inducing agent as these medications significantly decrease the concentration of Paxlovid and thus decrease its effectiveness. Holding the interacting medicines is not an option as the enzyme induction effect does not immediately dissipate when a medication is stopped. Alternative COVID treatment should be considered in patients that have taken an enzyme inducer within the past 14 days. Common drugs include anticonvulsants (carbamazepine, eslicarbazepine, oxcarbazepine, phenobarbital, phenytoin, primidone), antimycobacterials (rifampin), and St. John’s Wort.

Medications dependent on CYP3A4 metabolism 

The onset of CYP3A4 inhibition by ritonavir is rapid and significant. It can lead to high serum concentrations of some medications which can lead to serious adverse events. For drugs with a prolonged half-life, stopping the medication will not help reduce the interaction risk as the medication is slowly eliminated from the body, and an alternative COVID-19 treatment should be used. Common drugs include antiarrhythmics (amiodarone, dronedarone, flecainide, propafenone, quinidine), antipsychotics (lurasidone, clozapine), and fentanyl.

Some medications may either be held, dose-adjusted, or changed to alternative therapy temporarily while on Paxlovid.

Anticoagulants (apixaban, edoxaban, rivaroxaban): Use alternative COVID-19 agent if possible. Otherwise, if used for venous thromboembolism; the anticoagulant should be held and restarted two days after completing the Paxlovid course and the patient should be bridged with a low molecular weight heparin. For atrial fibrillation, apixaban and edoxaban may be dose adjusted or an alternative COVID-19 treatment should be considered. There is no dose adjustment recommended for rivaroxaban; an alternative should be considered. If clinically appropriate, patients on warfarin should be monitored for signs of increased bleeding/bruising and INR.

Alfuzosin: Alfuzosin levels may be increased significantly; hold and restart two days after Paxlovid is completed.

Opioids (hydrocodone, oxycodone, tramadol): Opioid dose should be reduced temporarily and resume the usual dose two days after Paxlovid is completed.

Calcium channel blockers (amlodipine, diltiazem, felodipine, nifedipine, verapamil): Consider reducing the dose temporarily and resume the usual dose two days after Paxlovid is completed.

Atorvastatin/rosuvastatin: Hold and restart the usual dose two days after Paxlovid is completed. Dose reduction may be considered.

The list of interactions with Paxlovid is long. These are some of the commonly used medications that interact with Paxlovid and management strategies. Pharmacists can be a valuable resource for assessing and helping manage these interactions.

Param Patel is a pharmacist.

Image credit: Shutterstock.com

Prev

Will Biden's State of the Union remarks revive prescription drug reform?

April 7, 2022 Kevin 0
…
Next

Primary care should be the center of gravity in health care [PODCAST]

April 7, 2022 Kevin 0
…

Tagged as: COVID, Infectious Disease, Medications

Post navigation

< Previous Post
Will Biden's State of the Union remarks revive prescription drug reform?
Next Post >
Primary care should be the center of gravity in health care [PODCAST]

Related Posts

  • A drug problem in rural Georgia

    Ashish Advani, PharmD
  • How hospitals can impact generic drug companies

    Mark Kelley, MD
  • Drug ads are a campaign against physician trust

    Judy Salz, MD
  • Crippling drug costs: the role of insurers

    Janice Boughton, MD
  • The complications of drug regulation

    Julie Craig, MD
  • A missed opportunity to fix drug pricing

    Brian C. Joondeph, MD

More in Meds

  • From Moscow Mule to the opioid crisis: Unveiling the tragic legacy and urgent solutions

    Osmund Agbo, MD
  • The deadly consequences of a shortage: The Pluvicto crisis leaves metastatic prostate cancer patients in limbo

    Matt Drewes
  • The real story of Xylazine contamination in street fentanyl and how we can manage it

    Julie Craig, MD
  • The cannabis education gap: Why patients are left in the dark

    Timothy Byars
  • Are doctors ready to discuss psychedelic therapies with patients?

    Thaís Salles Araujo, MD
  • The rise and dark side of fungi: Exploring health benefits and pathogenic threats

    Sandra Vamos, EdD and Deanna Lernihan, MPH
  • Most Popular

  • Past Week

    • A physician’s typical day, as envisioned by a non-clinician health care MBA: a satire

      Jennifer Lycette, MD | Physician
    • The rising threat of lung cancer in Asian American female nonsmokers

      Alice S. Y. Lee, MD | Conditions
    • Revealing America’s expansion: the dark truth of Native American suffering and unjustified abuses

      Anonymous | Physician
    • Georgia’s new law promoting truth and transparency in health care credentials

      Carmen Kavali, MD | Policy
    • The tragic story of Mr. G: a painful journey towards understanding suicide

      William Lynes, MD | Physician
    • Decoding name displays in health care: Privacy, identification, and compliance unveiled

      Deepak Gupta, MD | Physician
  • Past 6 Months

    • “Is your surgeon really skilled? The hidden threat to public safety in medicine.

      Gene Uzawa Dorio, MD | Physician
    • A physician’s typical day, as envisioned by a non-clinician health care MBA: a satire

      Jennifer Lycette, MD | Physician
    • Unveiling the hidden damage: the secretive world of medical boards

      Alan Lindemann, MD | Physician
    • Proactive risk management: a game-changer in preventing physician burnout

      Howard Smith, MD | Physician
    • An inspiring tribute to an exceptional radiologist who made a lasting impact

      Kim Downey, PT | Conditions
    • The hidden factor in physician burnout: How the climate crisis is contributing to the erosion of well-being

      Elizabeth Cerceo, MD | Physician
  • Recent Posts

    • Physician excellence: Transitioning from the comfort zone to the growth zone for exceptional patient care

      Harvey Castro, MD, MBA | Physician
    • Pursuing undergrad research without misrepresenting your career path

      Paris H. Grey and David G. Oppenheimer, PhD | Education
    • How healthy eating can protect us from extreme weather

      R. Jason Newsom, MD, MPH | Policy
    • Unfilled residency spots and the future of emergency medicine [PODCAST]

      The Podcast by KevinMD | Podcast
    • How excessively regulating doctors can harm patients

      Richard Gunderman, MD, PhD and James Lynch, MD | Physician
    • AI-driven solutions for burnout, patient empathy, and worker shortage

      Harry Severance, MD | Tech

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • Are Engineering and Medicine Good Bedfellows?
  • Poor Nutrition Status Linked With Survival After MitraClip
  • Hooray! A Clearer Estimate of Your Risk for Death Is Around the Corner
  • Transapical Transcatheter Mitral Valve Replacement Trial Raises Questions
  • Americans With Heart Disease Less Likely to Use Wearable Devices

Meeting Coverage

  • Poor Nutrition Status Linked With Survival After MitraClip
  • Transapical Transcatheter Mitral Valve Replacement Trial Raises Questions
  • MitraClip Shines in Real-World, Core-Lab Data
  • Risankizumab Safe in Older Crohn's Disease Patients
  • How to Better Identify HER2-Low Breast Cancer
  • Most Popular

  • Past Week

    • A physician’s typical day, as envisioned by a non-clinician health care MBA: a satire

      Jennifer Lycette, MD | Physician
    • The rising threat of lung cancer in Asian American female nonsmokers

      Alice S. Y. Lee, MD | Conditions
    • Revealing America’s expansion: the dark truth of Native American suffering and unjustified abuses

      Anonymous | Physician
    • Georgia’s new law promoting truth and transparency in health care credentials

      Carmen Kavali, MD | Policy
    • The tragic story of Mr. G: a painful journey towards understanding suicide

      William Lynes, MD | Physician
    • Decoding name displays in health care: Privacy, identification, and compliance unveiled

      Deepak Gupta, MD | Physician
  • Past 6 Months

    • “Is your surgeon really skilled? The hidden threat to public safety in medicine.

      Gene Uzawa Dorio, MD | Physician
    • A physician’s typical day, as envisioned by a non-clinician health care MBA: a satire

      Jennifer Lycette, MD | Physician
    • Unveiling the hidden damage: the secretive world of medical boards

      Alan Lindemann, MD | Physician
    • Proactive risk management: a game-changer in preventing physician burnout

      Howard Smith, MD | Physician
    • An inspiring tribute to an exceptional radiologist who made a lasting impact

      Kim Downey, PT | Conditions
    • The hidden factor in physician burnout: How the climate crisis is contributing to the erosion of well-being

      Elizabeth Cerceo, MD | Physician
  • Recent Posts

    • Physician excellence: Transitioning from the comfort zone to the growth zone for exceptional patient care

      Harvey Castro, MD, MBA | Physician
    • Pursuing undergrad research without misrepresenting your career path

      Paris H. Grey and David G. Oppenheimer, PhD | Education
    • How healthy eating can protect us from extreme weather

      R. Jason Newsom, MD, MPH | Policy
    • Unfilled residency spots and the future of emergency medicine [PODCAST]

      The Podcast by KevinMD | Podcast
    • How excessively regulating doctors can harm patients

      Richard Gunderman, MD, PhD and James Lynch, MD | Physician
    • AI-driven solutions for burnout, patient empathy, and worker shortage

      Harry Severance, MD | Tech

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...